SCHEMBL5468253

SCHEMBL5468253

CCc1cccc(NS(=O)(=O)N2CCCC(F)(F)C2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.39
OPRM1 P35372 3/20 0.36
ALOX5AP P20292 2/20 0.36
FEN1 P39748 2/20 0.36
CXCR2 P25025 5/20 0.34
KIF18A Q8NI77 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
FKBP1A P62942 1/20 0.33
OPRK1 P41145 1/20 0.33
CTPS1 P17812 1/20 0.32
SCN5A Q14524 1/20 0.32
SCN9A Q15858 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5476374 0.83 ALDH1A1 (0.46) HSD11B1CXCR2ALDH1A1KDM4EHPGD
SCHEMBL5473684 0.83 ALDH1A1 (0.46) HSD11B1CXCR2ALDH1A1KDM4EHPGD
SCHEMBL14581868 0.76 HSD11B1 (0.42) HSD11B1CXCR2ALDH1A1KDM4EHPGD
SCHEMBL5471117 0.76 POLB (0.42) HSD11B1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5481988 0.75 HSD11B1 (0.43) HSD11B1ALDH1A1LMNAMAPT
SCHEMBL14581789 0.75 HSD11B1 (0.43) HSD11B1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5468378 0.75 USP5 (0.42) HSD11B1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5476467 0.74 HSD11B1 (0.44) HSD11B1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14581938 0.74 HSD11B1 (0.45) HSD11B1ALDH1A1KDM4EHPGDLMNA
SCHEMBL5476488 0.74 HSD11B1 (0.40) HSD11B1CXCR2CTPS1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives HSD11B1, HSD11B2, HSD17B11 HSD11B1 1/4885OPRM1 2865/4885ALOX5AP 3426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.